AI SEO for Oncology: How to Get Recommended When Patients Ask ChatGPT

Patients facing a cancer diagnosis research differently than almost any other healthcare consumer. They are not comparison-shopping a commodity. They are making a life-altering decision under time pressure, often while managing fear, conflicting opinions from family, and incomplete information from a referring physician. The searches they run reflect that weight — and increasingly, they run them inside AI chat tools expecting a direct, named answer.

Right now, those tools usually return something like: "Top cancer centers for triple-negative breast cancer include MD Anderson, Memorial Sloan Kettering, and Mayo Clinic. Costs vary widely depending on staging and insurance coverage." A category-level answer. No local practice named. No community oncologist surfaced. If your practice treats these patients — and you do — the AI doesn't know that yet.

Patients Ask AI About Second Opinions, Clinical Trials, and Treatment Comparisons — Not Just "Oncologist Near Me"

Oncology patients rarely type a simple provider search. They ask layered clinical questions that reveal where they are in the decision process: "Is it worth getting a second opinion on pancreatic cancer," "Immunotherapy vs chemo for stage IV lung cancer — which is better," "How to get a second opinion without offending my oncologist." These queries signal a patient who already has a diagnosis and is evaluating next steps — the exact patient a community oncology practice or academic-affiliated group wants to reach.

When a patient asks ChatGPT or Perplexity "best hospitals for triple negative breast cancer treatment," the AI assembles its answer from structured data it can verify: published specialties, named physicians with documented expertise, patient reviews mentioning that disease site, and content on your own site that matches the question's clinical specificity. If your website says "we treat breast cancer" but never mentions triple-negative subtypes, HER2-negative protocols, or PARP inhibitors by name, the AI has nothing to anchor a recommendation on. The nationally branded centers win that answer by default — not because they are better for every patient, but because their digital footprint is disease-site specific.

The Referral-Driven Funnel Makes AI Visibility a Different Problem Than Paid Search

Oncology's acquisition funnel is overwhelmingly referral-driven. A PCP or surgeon sends the patient to you. But here is what has changed: patients now validate that referral before they schedule. They ask AI tools "clinical trials for recurrent ovarian cancer" or "do I need to travel for proton beam therapy" to decide whether the referred practice is sufficient or whether they should seek care elsewhere.

This means AI visibility in oncology is not about capturing a cold lead. It is about retaining a warm referral. The patient already has your name from their surgeon. They type it into ChatGPT alongside their disease and stage. If the AI returns nothing specific — or worse, names a competitor with clearer published expertise — you lose a patient you technically already had. The economics here are stark: a single oncology patient represents months or years of treatment cycles, imaging, lab work, and supportive care. Losing that patient at the validation step, after the referral was already made, is a failure that compounds across every downstream visit.

Why Your Google Business Profile, Reviews, and Website Must Tell One Consistent Story About Disease Sites You Treat

AI tools cross-reference at least three sources before naming a specific practice: your Google Business Profile (specialty categories, services listed, Q&A answers), your reviews (do patients mention specific cancers, specific treatments, specific physicians by name?), and your website (does it contain pages dedicated to the disease sites and modalities you actually deliver?). When all three agree — your profile says you offer immunotherapy, a patient review says "Dr. Martinez explained my pembrolizumab protocol clearly," and your site has a page on checkpoint inhibitor therapy for non-small cell lung cancer — the AI has enough corroboration to name you.

When they disagree or stay vague, the AI defaults to national brands or returns a generic list. The fix is not complicated, but it is specific to oncology's breadth: you likely treat dozens of disease sites across solid tumors and hematologic malignancies. Each one needs its own explicit presence across all three sources. A single "Our Services" page listing "chemotherapy, radiation, immunotherapy" gives the AI nothing to match against a patient asking about recurrent ovarian cancer specifically.

Reviews That Mention Disease Sites and Treatment Modalities Carry More Weight Than Star Ratings Alone

A five-star review that says "great office, friendly staff" does almost nothing for AI recommendation. A four-star review that says "I came here for a second opinion on my stage IIIB pancreatic adenocarcinoma and the team walked me through FOLFIRINOX versus gemcitabine options" gives the AI a verified, disease-specific signal it can match against patient queries.

You cannot script patient reviews. But you can prompt specificity at the right moment — after a treatment milestone, after a scan shows response, after a clinical trial enrollment. The review request itself can ask "What brought you to our practice and what has your experience been?" rather than "Please leave us a review." Patients in oncology are often deeply engaged with their care journey and willing to share detail. That detail is what separates your digital footprint from a generic listing.

Publishing Content That Matches How Patients Actually Phrase Their Questions to AI

Patients do not ask AI tools "what is the mechanism of action of nivolumab." They ask "immunotherapy vs chemo for stage IV lung cancer — which is better." They ask "do I need to travel for proton beam therapy." They ask "is it worth getting a second opinion on pancreatic cancer." Your site content needs to answer these questions in language that mirrors how they are asked — not in journal-article abstractions.

This means building pages or content sections around the actual decision points your patients face: When does a second opinion change the treatment plan? Which cancers respond to immunotherapy versus traditional cytotoxic regimens? What clinical trials are currently enrolling at your practice for specific disease sites? When is proton therapy indicated versus conventional radiation, and do patients need to travel for it? Each of these pages gives the AI a retrievable, verifiable answer it can attribute to your practice by name.

The Cost of Staying Invisible Is Measured in Lost Treatment Relationships, Not Lost Clicks

In oncology, a single lost patient is not a single lost visit. It is a lost relationship that may span initial staging, neoadjuvant therapy, surgery coordination, adjuvant cycles, surveillance imaging, and potentially years of maintenance therapy or survivorship care. The downstream revenue from one retained patient dwarfs what most other medical specialties see from a single acquisition.

Every week that your practice remains unnamed in AI answers to questions like "best hospitals for triple negative breast cancer treatment" or "clinical trials for recurrent ovarian cancer," you cede those validation moments to institutions whose digital presence is more specific than yours. The patients still get referred to you. They just leave before they arrive.

The work to fix this is not mysterious. It is disease-site-specific content on your website, consistent service listings on your Google profile, reviews that mention real treatments by name, and alignment across all three. You can direct this work yourself — set the disease sites, approve the content, review the listings — without handing control to an outside team that does not understand your tumor board or your referral relationships.

Start your free trial with Viotto